Role of autologous CD4+ T cell clones in human B non-Hodgkin's lymphoma: Aborted activation and G1 blockade induced by cell-cell contact

European Journal of Immunology

Volumn 29, Issue 10, 1999, Pages 3188-3195

  Martin, Isabelle ^a   Bonnefoix, Thierry ^a   Roucard, Corinne ^a   Perron, Pascal ^a   Lajmanovich, Alicia ^a   Moine, Agnès ^b   Leroux, Dominique ^a   Sotto, Jean Jacques ^a   Garban, Frédéric ^a,c  

^a CHU La Tronche and University   (France)

^b Ctr Departemental Transfus Sang   (France)

^c INSTITUT ALBERT BONNIOT   (France)

Author keywords

B lymphoma; CD4+ T lymphocyte; HLA class II; Ki 67

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; KI 67 ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL ACTIVATION; CELL CONTACT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL SEPARATION; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE CLONE; LYMPHOCYTE CULTURE; LYMPHOMA CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL COMMUNICATION; CELL CYCLE; CELL DIVISION; CLONE CELLS; COCULTURE TECHNIQUES; G1 PHASE; HUMANS; INTERLEUKIN-4; KI-67 ANTIGEN; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MEMBRANE GLYCOPROTEINS;

EID: 0032824537     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199910)29:10<3188::AID-IMMU3188>3.0.CO;2-D     Document Type: Article

References (23)

1. Luna-Fineman, S., Lee, J. E., Wesley, P. K., Clayberger, C. and Krensky, A. M., Human cytotoxic T-lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major histocompatibility complex restricted fashion. Cancer 1992. 70: 2181-2186.
2. Shi, I., Bonnefoix, T., Heuzé-Le Vacon, F., Jacob, M. C., Leroux, D., Gressin, R., Sotto, M. F., Chaffanjou, P., Bensa, J. C. and Sotto, J. J., Autotumor reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non Hodgkin's lymphomas. Br. J. Haematol. 1995. 90: 837-843.
3. Plumas, J., Chaperot, L., Jacob, M. C., Molens, J. P., Giroux, C., Sotto, J. J. and Bensa, J. C., Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells. Eur. J. Immunol. 1995. 25: 3332-3341.
4. Nelson, E. L., Li, X., Hsu, F. J., Kwak, L. W., Levy, R., Clayberger, C. and Krensky, A. M., Tumor specific, cytotoxic T lymphocyte after idiotype vaccination for B cell, non hodgkin's lymphoma. Blood 1996. 88: 580-589.
5. Schultze, J. L., Seamon, M. J., Michalak, K., Gribben, J. G. and Nadler, L. M., Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cell can be expanded in vitro. Blood 1997. 89: 3806-3816.
6. Yamamura, Y., Rodriguez, N., Schwartz, A., Eylar, E., Bagwell, B. and Yano, N., A new flow cytometric method for quantitative assessment of lymphocyte mitogenic potentials. Cell. Mol. Biol. 1995. 41: S121-S132.
7. Gruss, H. J., Herrmann, F., Gattei, V., Gloghini, A., Pinto, A. and Carbone, A., CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues. Leuk. Lymphoma 1996. 24: 393-422.
8. Umetsu, D. T., Esserman, L., Donlon, T. A., DeKruyff, R. H. and Levy, R., Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J. Immunol. 1990. 144: 2550-2557.
9. Chaperot, L., Delfau Larue, H., Jacob, M. C., Molens, J. P., Roussel, B., Agrawal, S., Farcet, J. P., Gressin, R., Sotto, J. J., Bensa, J. C. and Plumas, J., Differentiation of autotumor specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas. Exp. Hematol. 1999. 27: 1185-1193.
10. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., Van Kooten, C., Liu, Y. J., Rousset, F. and Saeland, S., The CD40 antigen and its ligand. Annu. Rev. Immunol. 1994. 12: 881-922.
11. Buske, C., Twilling, A., Gogowski, G., Schreiber, K., Feuring-Buske, M., Wulf, G., Hiddemann, W. and Wormann, B., In vitro activation of low grade non hodgkin lymphoma by murine fibroblasts, IL4, anti-CD40 antibodies and the soluble CD40 ligand. Leukemia 1997. 11: 1862-1867.
12. Johnson-Leger, C., Christenson, J. R., Holman, M. and Klaus, G. B., Evidence for a critical role for IL-12 in CD40 mediated activation of naive B cells by primary CD4 T cells. J. Immunol. 1998. 161: 4618-4626.
13. Garban, F., Truman, J. P., Lord, J., Drénou, B., Plumas, J., Jacob, M. C., Sotto, J. J., Charron, D. J. and Mooney, N. A., Signal transduction via human leukocyte antigen class II molecules distinguishes between cord blood, normal, and malignant adult B lymphocytes. Exp. Hematology 1998. 26: 874-884.
14. Schultze, J. L., Cardoso, A., Freeman, G. J., Seamon, M. J., Daley, J., Pinkus, G. S., Gribben, J. G. and Nadler, L. M., Follicular lymphomas can be induced to present alloantigen efficiently: a conceptuel model to improve their immunogenicity. Proc. Natl. Acad. Sci. USA 1995. 92: 8200-8204.
15. Chaperot, L., Plumas, J., Jacob, M. C., Bost, F., Molens, J. P., Sotto, J. J. and Bensa, J. C., Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non Hodgkin's lymphomas. Exp. Hematol. 1999. 27: 479-488.
16. Dorfman, D. M., Schultze, J. L., Shahsafaei, A., Michalak, S., Gribben, J. G., Freeman, G. J., Pinkus, G. S. and Nadler, L. M., In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation. Blood 1997. 90: 4297-4306.
17. Jaiswal, A. and Croft, M., CD40 ligand induction on T cell subsets by peptide-presenting B cells. Implications for development of the primary T and B cell response. J. Immunol. 1997. 159: 2282-2291.
18. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G. and Levy, R., Vaccination of patients with B cell lymphoma using autologous pulsed dendritic cells. Nature Med. 1996. 2: 52-58.
19. Chaux, P., Vantomme, V., Stroobant, V., Thielmans, K., Corthals, J., Luiten, R., Eggermont, A. M. M., Boon, T. and van der Bruggen, P., Identification of MAGE3 epitopes presented by HLA-DR molecules to CD4 T lymphocytes. J. Exp. Med. 1999. 189: 767-777.
20. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K., Cleary, M. L., Delsol, G. L., De Wolf Peeters, C., Falini, B. and Gatter, K. C., A revised European American classification of lymphoid neoplasm: a proposal from the international lymphoma study group. Blood 1994. 84: 1361-1392.
21. Bonnefoix, T., Bonnefoix, P., Verdiel, P. and Sotto, J. J., Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit Poisson assumption. J. Immunol. Methods 1996. 194: 113-119.
22. Trainor, K. J., Brisco, M. I., Wan, J. H., Neoh, S., Grist, S. and Morley, A. A., Gene rearrangement in B- and T-lymphoproliferative disease by the polymerase chain reaction. Blood 1991. 78: 192-196.
23. Shapiro, H. M:(Ed.) Practical Flow Cytometry. Alan R. Liss, New York 1988.